News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Rashid K. Sayyid: Updated PSMAfore OS data
Photo taken from Rashid K. Sayyid/X
Jun 11, 2024, 11:14

Rashid K. Sayyid: Updated PSMAfore OS data

Rashid K. Sayyid, urologic oncology fellow at Augusta University, shared a post on X:

“Updated PSMAfore OS data: LuPSMA vs ARPI change in ARPI pre-treated mCRPC
HR: 0.98 from 1.16 previously
OS maturity: ~46%
78% of eligible pts in ARPI change arm crossed over to LuPSMA.”

Rashid K. Sayyid

Source: Rashid K. Sayyid/X

Augusta University cancer OncoDaily Oncology Rashid K. Sayyid
Special Coverage
Blog
Sep 15, 2024, 06:03
Linghua Wang: NCI HTAN PreCancer Research Center grant to establish the Center for Gastric PreCancer Atlas
Blog
Sep 15, 2024, 02:18
Douglas Flora: We have a responsibility to create environments of productive conflict, not conflict for its own sake
Blog
Sep 15, 2024, 02:15
Julie Sprengel: I was proud to join members of our Dignity Health California to give back to our communities
Blog
Sep 15, 2024, 02:08
Sahar Barjesteh van Waalwijk: How can we make such medicines available through insurance coverage?
Insight
Sep 15, 2024, 01:34
Some perspective on TRUST-II with talectrectinib
Insight
Sep 15, 2024, 01:32
Kimryn Rathmell: Reflecting on my time spent recently at the Embassy of Japan
Insight
Sep 15, 2024, 01:29
Naveen Pemmaraju: Thank you for supporting our our inaugural MPN Workshop
Insight
Sep 15, 2024, 01:23
Erika Ruiz-Garcia: Contributing to the creation and development of the ASCO 2025 Annual Meeting Program
Insight
Sep 15, 2024, 01:17
Elizabeth Saenz: Stigma associated with opioids use for palliative care causes unnecessary suffering
Insight
Sep 15, 2024, 00:29
Breelyn Wilky on botensilimab and balstilimab for refractory sarcomas at ESMO24
Insight
Sep 14, 2024, 19:28
Paolo Tarantino: Are all residual diseases equal?
Insight
Sep 14, 2024, 19:20
Elvina Almuradova: The future treatment landscape for hepatocellular carcinoma looks hopeful